Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

This study has been terminated.
(Corporate re-prioritization)
Information provided by:
Arana Therapeutics Ltd Identifier:
First received: June 24, 2009
Last updated: January 4, 2010
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)